Comparative study of cisplatin-iodized oil suspension and emulsion for transcatheter arterial chemoembolization of rabbit VX2 liver tumors

Hepatology Research

Volumn 42, Issue 5, 2012, Pages 473-481

  Mine, Takahiko ^a   Murata, Satoru ^a   Ueda, Tatsuo ^a   Onozawa, Shiro ^a   Onda, Munehiko ^a   Naito, Zenya ^a   Kumita, Shinichiro ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cisplatin; Drug delivery systems; Hepatocellular carcinoma; Suspension; Transcatheter arterial chemoembolization; VX2 liver tumor

Indexed keywords

CISPLATIN;

ANIMAL CARE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; CANCER GROWTH; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EMULSION; HISTOPATHOLOGY; LIVER TOXICITY; LIVER TUMOR; NONHUMAN; PRIORITY JOURNAL; SUSPENSION;

EID: 84861315542     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00942.x     Document Type: Article

References (31)

1. Murata S, Tajima H, Nakazawa K et al. Initial experience of transcatheter arterial chemoembolization during portal vein occlusion for unresectable hepatocellular carcinoma with marked arterioportal shunts. Eur Radiol 2009; 19: 2016-23.
2. Lo CM, Ngan H, Tso WK et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-71.
3. Llovet JM, Real MI, Montaña X et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-9.
4. Morimoto K, Sakaguchi H, Tanaka T et al. Transarterial chemoembolization using cisplatin powder in a rabbit model of liver cancer. Cardiovasc Intervent Radiol 2008; 31: 981-5.
5. Kawaoka T, Aikata H, Takaki S et al. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma. Cardiovasc Intervent Radiol 2009; 32: 687-94.
6. Lai CL, Wu PC, Chan GC et al. Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer 1988; 62: 479-83.
7. Okada S, Okazaki N, Nose H et al. A phase 2 study of cisplatin in patients with hepatocellular carcinoma. Oncology 1993; 50: 22-6.
8. Abe R, Akiyoshi T, Koba F et al. "Two-route chemotherapy" using intra-arterial cisplatin and intravenous sodium thiosulfate, its neutralizing agent, for hepatic malignancies. Eur J Cancer Clin Oncol 1988; 24: 1671-4.
9. Ikeda M, Maeda S, Ashihara H et al. Transcatheter arterial infusion chemotherapy with cisplatin-lipiodol suspension in patients with hepatocellular carcinoma. J Gastroenterol 2010; 45: 60-7.
10. Okusaka T, Okada S, Ueno H et al. Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma. Oncology 2000; 58: 293-9.
11. Yoshikawa M, Saisho H, Ebara M et al. A randomized trial of intrahepatic arterial infusion of 4′-epidoxorubicin with Lipiodol versus 4′-epidoxorubicin alone in the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol 1994; 33: S149-S152.
12. Yoon CJ, Chung JW, Park JH et al. Transcatheter arterial chemoembolization with paclitaxel-lipiodol solution in rabbit VX2 liver tumor. Radiology 2003; 229: 126-31.
13. Takayasu K, Shima Y, Muramatsu Y et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987; 163: 345-51.
14. Yamamoto K, Shimizu T, Narabayashi I. Intraarterial infusion chemotherapy with lipiodol-CDDP suspension for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2000; 23: 26-39.
15. Demachi H, Matsui O, Abo H et al. Simulation model based on non-Newtonian fluid mechanics applied to the evaluation of the embolic effect of emulsions of iodized oil and anticancer drug. Cardiovasc Intervent Radiol 2000; 23: 285-90.
16. Kan Z, Wright K, Wallace S. Ethiodized oil emulsions in hepatic microcirculation: in vivo microscopy in animal models. Acad Radiol 1997; 4: 275-82.
17. Ko YH, Pedersen PL, Geschwind JF. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett 2001; 173: 83-91.
18. Kan Z, Sato M, Ivancev K et al. Distribution and effect of iodized poppyseed oil in the liver after hepatic artery embolization: experimental study in several animal species. Radiology 1993; 186: 861-6.
19. Miller DL, O'Leary TJ, Girton M. Distribution of iodized oil within the liver after hepatic arterial injection. Radiology 1987; 162: 849-52.
20. Kan Z, Ivancev K, Hagerstrand I et al. In vivo microscopy of the liver after injection of Lipiodol into the hepatic artery and portal vein in the rat. Acta Radiol 1989; 30: 419-25.
21. Sakurai M, Okamura J, Kuroda C. Transcatheter chemoembolization effective for treating hepatocellular carcinoma: a histopathologic study. Cancer 1984; 54: 387-92.
22. Cao W, Wan Y, Liang ZH et al. Heated lipiodol as an embolization agent for transhepatic arterial embolization in VX2 rabbit liver cancer model. Eur J Radiol 2010; 73: 412-9.
23. Garin E, Denizot B, Roux J et al. Effect of stabilized iodized oil emulsion on experimentally induced hepatocellular carcinoma in rats. J Vasc Interv Radiol 2005; 16: 841-8.
24. de Baere T, Zhang X, Aubert B et al. Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study. Radiology 1996; 201: 731-5.
25. de Baere T, Dufaux J, Roche A et al. Circulatory alterations induced by intra-arterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study. Radiology 2005; 194: 165-70.
26. Nakamura H, Hashimoto T, Oi H et al. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1989; 170: 783-6.
27. Zamboni WC, Gervais AC, Egorin MJ et al. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin. Clin Cancer Res 2002; 8: 2992-9.
28. Erdlenbruch B, Nier M, Kern W et al. Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients. Eur J Clin Pharmacol 2001; 57: 393-402.
29. Gratton MA, Smyth BJ. Cisplatin: continuous versus bolus. J Pediatr Hematol Oncol 2006; 28: 60-1.
30. Sasaki Y, Imaoka S, Kasugai H et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 1987; 60: 1194-203.
31. Kanematsu T, Furuta T, Takenaka K et al. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989; 10: 98-102.